What is the global market size of Consumer Healthcare Market?

Consumer Healthcare Market size was valued at USD 339.22 billion in 2021 and is poised to grow from USD 364.41 billion in 2022 to USD 646.65 billion by 2030, growing at a CAGR of 7.43% in the forecast period (2023-2030).

Who are the key vendors in the Global Consumer Healthcare Market?

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China. 'Johnson & Johnson', 'Procter & Gamble', 'GlaxoSmithKline plc', 'Pfizer Inc.', 'Novartis International AG', 'Sanofi', 'Bayer AG', 'Reckitt Benckiser Group plc', 'Abbott Laboratories', 'Merck & Co., Inc.', 'Nestlé S.A.', 'Colgate-Palmolive Company', 'Boehringer Ingelheim GmbH', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Perrigo Company plc', 'Allergan plc', 'GlaxoSmithKline Consumer Healthcare.', 'In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.', 'In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.', 'In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.'

What is the key driver of Global Consumer Healthcare Market?

Easy Availability and High Awareness Among Consumers Driving Growth of Consumer Healthcare Market

What is the key market trend for Global Consumer Healthcare Market?

People all across the world are becoming more health-conscious and aware of the influence of individual lifestyle choices on their own and others' health. This rising understanding has the potential to change the way we think about health care, causing us to become our own health advocates, exploring strategies to enhance and preserve our own health. This global trend of health ownership is predicted to stimulate growth of the consumer healthcare market on a variety of fronts. Furthermore, self-care can help alleviate the increasing resource strain on healthcare systems and governments.

Which region accounted for the largest share in Global Consumer Healthcare Market?

The Asia Pacific consumer healthcare market is projected to continue witnessing the fastest growth during the forecast period by the virtue of shift in consumer attitudes toward self-medication, an increase in the elderly population, a quick move from Rx to OTC, and the affordability of OTC medications. Europe is estimated to be the second-largest market during the forecast period due to the increasing acceptance of self-medication and the existence of a significant number of OTC medicine manufacturing firms in this region. In addition, increased public awareness of OTC products is propelling the expansion of consumer healthcare market in the region.

Top Consumer Healthcare Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Consumer Healthcare Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Consumer Healthcare industry players.

Consumer Healthcare Market Competitive Landscape

In terms of revenue, GSK is dominating the global consumer healthcare market. Wherein, the oral health and pain relief segment is dominating the market and is expected to do so in the coming years. On the other hand, J&J invested the hefty sum in the consumer healthcare segment between the years 2016 and 2020 followed by Pfizer and GSK to attain large market share and tap the lucrative growth opportunity, especially in developing market like India and China.

Consumer Healthcare Market Top Players Company Profiles

Johnson & Johnson
Procter & Gamble
GlaxoSmithKline plc
Pfizer Inc.
Novartis International AG
Sanofi
Bayer AG
Reckitt Benckiser Group plc
Abbott Laboratories
Merck & Co., Inc.
Nestlé S.A.
Colgate-Palmolive Company
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Perrigo Company plc
Allergan plc
GlaxoSmithKline Consumer Healthcare.

Recent Developments in Global Consumer Healthcare Market

In February 2022, GlaxoSmithKline plc (GSK) revealed the name of the new business that would emerge from GSK's proposed demerger of Consumer Healthcare in mid-2022, Haleon.
In February 2022, Ipsen engaged in a divestment agreement with Mayoly Spindler, a French pharmaceutical company, in which Ipsen decided to sell its global consumer health portfolio.
In January 2022, GSK, one of the key players in the global consumer healthcare market, strategized to sell its consumer health unit to Unilever and Pfizer as consumer health joint venture. However, Unilever will not increase its bid for the GSK-Pfizer consumer health joint venture above 50 billion pounds (USD 68 billion). With Unilever's exit, GSK is back to its original goal for a spinoff by mid-2022.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Consumer Healthcare Market size was valued at USD 302.36 Billion in 2024 and is poised to grow from USD 325.34 Billion in 2025 to USD 584.57 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026–2033).

The key vendors in the Consumer Healthcare Market include Johnson & Johnson, Bayer AG, Haleon plc, Procter & Gamble Company, Sanofi S.A., Kenvue Inc., Abbott Laboratories, Reckitt Benckiser Group plc, GlaxoSmithKline plc, and Perrigo Company plc. These companies offer over-the-counter medicines, vitamins and supplements, personal care products, and self-care solutions.

The key driver of the Consumer Healthcare Market is the growing consumer preference for self-medication and preventive healthcare. Rising awareness of wellness, increasing demand for over-the-counter medicines, vitamins and supplements, and expanding access to digital health information further support market growth.

The key market trend in the Consumer Healthcare Market is the growing shift toward personalized wellness, preventive healthcare, and digital purchasing channels. Consumers are increasingly choosing immunity supplements, functional health products, and convenient over-the-counter treatments, while brands leverage e-commerce and digital platforms to improve accessibility and engagement.

North America accounted for the largest share of the Consumer Healthcare Market, driven by high consumer awareness, strong purchasing power, and widespread availability of over-the-counter medicines and wellness products. Established retail networks, advanced healthcare infrastructure, and growing demand for preventive healthcare further support regional market dominance.

Top Consumer Healthcare Companies

Consumer Healthcare Market Competitive Landscape

FAQs

What is the global market size of Consumer Healthcare Market?

Who are the key vendors in the Consumer Healthcare Market?

What is the key driver of Consumer Healthcare Market?

What is the key market trend for Consumer Healthcare Market?

Which region accounted for the largest share in Consumer Healthcare Market?

Request Free Customization